Real-Time MRI-Guided Prostate Interventions
- PMID: 35454773
- PMCID: PMC9030365
- DOI: 10.3390/cancers14081860
Real-Time MRI-Guided Prostate Interventions
Abstract
Prostate cancer (PCa) is the second most common cause of cancer death in males. Targeting MRI-visible lesions has led to an overall increase in the detection of clinically significant PCa compared to the prior practice of random ultrasound-guided biopsy of the prostate. Additionally, advances in MRI-guided minimally invasive focal treatments are providing new options for patients with PCa. This review summarizes the currently utilized real-time MRI-guided interventions for PCa diagnosis and treatment.
Keywords: MRI-guided prostate interventions; multiparametric magnetic resonance imaging (mpMRI); prostate ablation; prostate biopsy; prostate cancer (PCa).
Conflict of interest statement
Author P.G. is on the Medical Advisory Boards of INSIGHTEC and SonoALASense and has an ownership/equity interest in SonoALASense. Author A.O. is the co-founder and co-owner of QMIS; he is on the Medical Advisory Board of Profound and has research grants from Profound and Philips. Author S.A. is involved with a clinical trial and has research support from Profound. The remaining authors declare no conflict of interest.
Figures






References
-
- GLOBOCAN World Health Organization. [(accessed on 2 February 2022)]. Available online: https://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-she....
-
- Schröder F.H., Hugosson J., Roobol M.J., Tammela T.L., Zappa M., Nelen V., Kwiatkowski M., Lujan M., Määttänen L., Lilja H., et al. ERSPC Investigators. Screening and prostate cancer mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet. 2014;384:2027–2035. doi: 10.1016/S0140-6736(14)60525-0. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources